Related Experiment Videos
Comparison between diploid and aneuploid hepatocellular carcinomas: a flow cytometric study
N Nagasue1, A Yamanoi, Y Takemoto
1Second Department of Surgery, Shimane Medical University, Izumo, Japan.
The British Journal of Surgery
|July 1, 1992
Summary
Nuclear DNA content analysis in hepatocellular carcinoma (HCC) did not predict patient outcomes. DNA ploidy status showed no significant correlation with survival or recurrence after surgical treatment.
Area of Science:
- Hepatobiliary Surgery
- Cancer Genomics
- Oncology
Background:
- Hepatocellular carcinoma (HCC) is a major global health concern.
- Accurate prognostic markers are crucial for guiding surgical treatment decisions in HCC.
- Nuclear DNA content (ploidy) is a potential biomarker in various cancers.
Purpose of the Study:
- To investigate the correlation between nuclear DNA content (ploidy) and clinicopathological features in HCC.
- To evaluate the predictive value of DNA ploidy for patient survival and tumor recurrence after hepatic resection.
Main Methods:
- Flow cytometry was used to determine nuclear DNA content in 91 HCC tumors.
- Retrospective analysis compared clinicopathological data between diploid and aneuploid HCC groups.
- Survival rates and intrahepatic recurrence were analyzed based on ploidy status.
Main Results:
- No significant correlation was found between DNA ploidy and age, sex, viral hepatitis, or serum alpha-fetoprotein levels.
- Diploid tumors showed a trend towards smaller size (<2 cm) and better differentiation.
- DNA ploidy did not influence tumor capsule formation, venous invasion, survival rates, or recurrence patterns.
Conclusions:
- Nuclear DNA ploidy is not a significant predictive factor for surgical treatment outcomes in hepatocellular carcinoma.
- Further research may be needed to identify more reliable prognostic markers for HCC.